Could cause temporary or reversible harm; serious harm is unlikely.
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
| Brand name | SUCCINYLCHOLINE |
| Generic name | SUCCINYLCHOLINE |
| Active ingredient(s) | SUCCINYLCHOLINE CHLORIDE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-666-25 |
| Full product label | Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide within the USA. |
| Quantity | 571 vials |
| Recall initiated | 2025-09-26 |
| Report date | 2025-10-15 |
| Recall completed | — |
| Recall number | D-0008-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗